LAG3 anticorps (N-Term) (Atto 647N)
Aperçu rapide pour LAG3 anticorps (N-Term) (Atto 647N) (ABIN2295904)
Antigène
Voir toutes LAG3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- N-Term
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- LAG-3 (ATTO 647N) (Lymphocyte Activation Gene-3, FDC Protein, CD223)
-
Pureté
- >95 % SDS-PAGE
-
Immunogène
- Synthetic peptide corresponding to 30 aa in the N-terminus of human LAG-3.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- +4°C/+4°C
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Autre désignation
- LAG-3
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Antigène
-